Cancer treatment using beta-(1-3)-(1-4)-glucan

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10946038
APP PUB NO 20190046557A1
SERIAL NO

16059511

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method of treating a subject having cancer is described that includes administering a therapeutically effective amount of a β-(1,3)-(1,4) glucan to the subject. Methods of immunostimulating in a subject by administering an effective amount of a β-(1,3)-(1,4) glucan to the subject are also described.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CASE WESTERN RESERVE UNIVERSITY10900 EUCLID CLEVELAND OH 44106

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Huang, Alex Y Cleveland, US 2 1
Kim, Julian Cleveland, US 6 4
Zhang, Mei Cleveland, US 133 2178

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 16, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 16, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00